We are live on ! Find out more

340 hedge funds and large institutions have $4.66B invested in Neogen in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 111 increasing their positions, 144 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $4.12B → $4.66B (+$541M)

4.27% more ownership

Funds ownership: 102.95%107.22% (+4.3%)

7% less funds holding

Funds holding: 366340 (-26)

23% less repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 144

24% less call options, than puts

Call options by funds: $8.76M | Put options by funds: $11.6M

35% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 57

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
340
Holders Change
-26
Holders Change %
-7.1%
% of All Funds
4.95%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
37
Increased
111
Reduced
144
Closed
57
Calls
$8.76M
Puts
$11.6M
Net Calls
-$2.82M
Net Calls Change
-$14.3M

NEOG Hedge Fund Activity: Q4 2023 in Review

340 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q4 2023, worth a combined $4.66B — up 13% from $4.12B a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of NEOG and 37 opened new positions — a net loss of 20 holders — while 144 trimmed existing stakes and 111 added.

The largest buyer was Baillie Gifford & Co, opening a new position worth an estimated $140M. The largest seller was Citadel Advisors, cutting an estimated $68.6M.

  • 340 institutional investors held Neogen (NEOG) as of Q4 2023, down from 366 in Q3 2023.
  • Funds reported $4.66B of Neogen stock for Q4 2023, up 13% quarter-over-quarter.
  • 37 funds opened new Neogen positions in Q4 2023 and 57 closed out, a net change of -20 holders.
  • The largest Neogen buyer in Q4 2023 was Baillie Gifford & Co, an estimated $140M added.
  • The largest Neogen seller in Q4 2023 was Citadel Advisors, an estimated $68.6M sold.

Based on aggregated 13F filings for Q4 2023.